tm logo
ALOCELLIX
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 29 Jul 2022

Last Applicant/ Owned by

Parque Tecnológico de Madrid C/ Marconi

1 Tres Cantos (Madrid)

ES

28760

Serial Number

86508189 filed on 20th Jan 2015

Registration Number

4888035 registered on 19th Jan 2016

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Troutman Pepper Hamilton Sanders LLP

c/o IP Services NYC

875 Third Avenue

New York NY 10022

Filing Basis

1. intent to use

Disclaimer

NO DATA

ALOCELLIX

Pharmaceutical preparations for medical use, namely, treatment of diseases with autoimmune and/or inflammatory component; diagnostic preparations for medical use; bacteriological and biological preparations for medical use; cellular implants and engineered cellular tissue for medical purposes, namely, stem cells for medical use

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for medical use, namely, treatment of diseases with autoimmune and/or inflammatory component; diagnostic preparations for medical use; bacteriological and biological preparations for medical use; cellular implants and engineered cellular tissue for medical purposes, namely, stem cells for medical use

Mark Details


Serial Number

No 86508189

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Jul 2022CANCELLED SEC. 8 (6-YR)
19th Jan 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02th Jul 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01st Jul 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01st Jul 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
01st Jul 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01st Jul 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01st Jul 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01st Jul 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
12th Dec 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED